Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares Apr 30, 2025
Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics Apr 14, 2025
Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025 Jan 31, 2025
